Related Articles
CDK4/6 inhibitor resistance mechanisms and treatment strategies (Review)
Inhibition of GP130/STAT3 and EMT by combined bazedoxifene and paclitaxel treatment in ovarian cancer
HSulf‑1 and palbociclib exert synergistic antitumor effects on RB‑positive triple‑negative breast cancer
Triple‑negative breast cancer therapy: Current and future perspectives (Review)
Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6